BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7489318)

  • 41. [Value of MR-guided localization and biopsy in breast lesions].
    Obenauer S; Grabbe E; Knollmann F
    Rofo; 2006 May; 178(5):477-83. PubMed ID: 16708322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current status of breast MR imaging. Part 2. Clinical applications.
    Kuhl CK
    Radiology; 2007 Sep; 244(3):672-91. PubMed ID: 17709824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
    Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The technique and results of mammography].
    Friedrich M
    Radiologe; 1993 May; 33(5):243-59. PubMed ID: 8516435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?
    Fallenberg EM; Dromain C; Diekmann F; Renz DM; Amer H; Ingold-Heppner B; Neumann AU; Winzer KJ; Bick U; Hamm B; Engelken F
    Breast Cancer Res Treat; 2014 Jul; 146(2):371-81. PubMed ID: 24986697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast imaging today and tomorrow.
    Cole CF; Coleman C
    Nurse Pract Forum; 1999 Sep; 10(3):129-36. PubMed ID: 10614357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feature extraction and classification of dynamic contrast-enhanced T2*-weighted breast image data.
    Torheim G; Godtliebsen F; Axelson D; Kvistad KA; Haraldseth O; Rinck PA
    IEEE Trans Med Imaging; 2001 Dec; 20(12):1293-301. PubMed ID: 11811829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer.
    Orel SG; Schnall MD
    Radiology; 2001 Jul; 220(1):13-30. PubMed ID: 11425968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Summaries for patients. Screening for breast cancer: U.S. Preventive Services Task Force recommendations.
    Ann Intern Med; 2009 Nov; 151(10):I44. PubMed ID: 19920254
    [No Abstract]   [Full Text] [Related]  

  • 50. Imaging the augmented breast.
    Kaufman BM; Lamarche J; Schultze-Haakh H
    Radiol Technol; 2007; 78(3):187-90. PubMed ID: 17242438
    [No Abstract]   [Full Text] [Related]  

  • 51. Anxiety and specific distress in women at intermediate and high risk of breast cancer before and after surveillance by magnetic resonance imaging and mammography versus standard mammography.
    Brédart A; Kop JL; Fall M; Pelissier S; Simondi C; Dolbeault S; Livartowski A; Tardivon A;
    Psychooncology; 2012 Nov; 21(11):1185-94. PubMed ID: 21812069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Mammography with minimal radiation dosage. Comparative studies on various imaging systems].
    Weissleder H; Kiefer H
    Rofo; 1977 Jun; 126(6):520-8. PubMed ID: 142713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast MR imaging screening in women with a history of breast conservation therapy.
    Gweon HM; Cho N; Han W; Yi A; Moon HG; Noh DY; Moon WK
    Radiology; 2014 Aug; 272(2):366-73. PubMed ID: 24635678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Economic aspects of MR-mammography in dense breasts.
    Kaiser CG; Reich C; Wasser K; Schönberg SO; Kaiser WA
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S69-71. PubMed ID: 23083609
    [No Abstract]   [Full Text] [Related]  

  • 55. Do we need randomized controlled clinical trials to evaluate the clinical impact of breast MR imaging?
    Hillman BJ
    Magn Reson Imaging Clin N Am; 2006 Aug; 14(3):403-9, vii-viii. PubMed ID: 17098181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. When and when not to biopsy the breast.
    Newstead G
    Diagn Imaging (San Franc); 1993 Mar; 15(3):111, 115-6. PubMed ID: 10148387
    [No Abstract]   [Full Text] [Related]  

  • 57. [Current status of screening digital mammography in Japan].
    Yamada T; Suzuki A
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():318-23. PubMed ID: 17679206
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparison of costs and benefits of breast cancer screening with mammography, ultrasonography, and MRI.
    Feig S
    Obstet Gynecol Clin North Am; 2011 Mar; 38(1):179-96, ix. PubMed ID: 21419333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Magnetic resonance imaging of the breast: costs and efficiency].
    Golder WA
    Onkologie; 2001 Apr; 24(2):185-8. PubMed ID: 11441302
    [No Abstract]   [Full Text] [Related]  

  • 60. [The significance of MDR (mammo digital-radiography) in breast cancer mass screening].
    Kido C
    Gan No Rinsho; 1989 May; Spec No():220-6. PubMed ID: 2689663
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.